Comphya closed an oversubscribed Series A round totaling CHF 7.5 million (~$8.4 million) to support clinical development of CaverSTIM, its implantable neurostimulation system targeting erectile
JenaValve has enrolled the first patient in its ARTIST trial, the first randomized controlled study comparing transcatheter aortic valve replacement (TAVR) with surgical aortic valve
Waters Corporation and BD (Becton, Dickinson and Company) have announced a definitive agreement to merge BD’s Biosciences & Diagnostic Solutions (BDS) business with Waters in
LivsMed has unveiled Stark, its new surgical robotic system designed natively for telesurgery, in partnership with Sovato. The company demonstrated Stark’s long-distance remote surgery capabilities
HistoSonics has secured four new positive medical policy decisions from Highmark Blue Cross Blue Shield, expanding insurance coverage for its non-invasive histotripsy treatment for liver
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
